Claudia Ordeanu1, Diana Cristina Pop1, Radu Badea2, Csaba Csutak3, Nicolae Todor4, Calin Ordeanu5, Reka Kerekes6, Ovidiu Coza7, Viorica Nagy7, Patriciu Achimas-Cadariu8, Alexandru Irimie8. 1. Department of Radiotherapy with High Energies and Brachytherapy, Oncology Institute "Prof. Dr. Ion Chiricuta", Street Republicii, No. 34-36, 400015 City of Cluj-Napoca, Cluj County, Romania. 2. Adults Clinical Hospital, Medical Clinic No. III, Street Croitorilor, No. 19-21, 400162 City of Cluj-Napoca, Cluj County, Romania ; University of Medicine and Farmacy "Iuliu Hatieganu", Street Louis Pasteur, No. 4, 400349 City of Cluj-Napoca, Cluj County, Romania ; Badea Medica Clinic, Street René Descartes, No. 27, 400486 City of Cluj-Napoca, Cluj County, Romania. 3. University of Medicine and Farmacy "Iuliu Hatieganu", Street Louis Pasteur, No. 4, 400349 City of Cluj-Napoca, Cluj County, Romania ; Scandia Imagistica Medical Clinic, Street Ciresilor, No. 15C, 400487 City of Cluj-Napoca, Cluj County, Romania. 4. Department of Biostatistics and Medical Informatics, Oncology Institute "Prof. Dr. Ion Chiricuta", Street Republicii, No. 34-36, 400015 City of Cluj-Napoca, Cluj County, Romania. 5. Clinical Hospital of Surgery and Orthopaedics "Alexandru Radulescu", Street General Traian Mosoiu, No. 47-49, 400132 City of Cluj-Napoca, Cluj County, Romania. 6. University of Medicine and Farmacy "Iuliu Hatieganu", Street Louis Pasteur, No. 4, 400349 City of Cluj-Napoca, Cluj County, Romania ; Clinical County Emergency Hospital, Street Clinicilor, No. 3-5, 400006, City of Cluj-Napoca, Cluj County, Romania. 7. Department of Radiotherapy with High Energies and Brachytherapy, Oncology Institute "Prof. Dr. Ion Chiricuta", Street Republicii, No. 34-36, 400015 City of Cluj-Napoca, Cluj County, Romania ; University of Medicine and Farmacy "Iuliu Hatieganu", Street Louis Pasteur, No. 4, 400349 City of Cluj-Napoca, Cluj County, Romania. 8. University of Medicine and Farmacy "Iuliu Hatieganu", Street Louis Pasteur, No. 4, 400349 City of Cluj-Napoca, Cluj County, Romania ; Department of Surgery, Oncology Institute "Prof. Dr. Ion Chiricuta", Street Republicii, No. 34-36, 400015 City of Cluj-Napoca, Cluj County, Romania.
Abstract
OBJECTIVE: The aim of study was to analyze the accuracy of TRUS (transrectal ultrasound) vs. MRI (magnetic resonance imaging) and clinical gynecological examination estimation in the evaluation of tumor dimensions. METHODS: The patients inclusion criterion included primarily pathologically squamous cell carcinoma, but excluded were patients who had not undergone BT (brachytherapy) and treated with palliative intent. We offer two types of treatment for locally advanced cervical cancer: (a) radiochemotherapy followed by surgery and (b) exclusive radiochemotherapy. Imaging tests follow the presence of tumor and tumor size (width and thickness). Each examination was performed by a different physician who had no knowledge of the others' findings. All patients underwent MRI prior to EBRT (external beam radiation therapy) while 18 of them also at the time of the first brachytherapy application. For the analysis we used the r-Pearson correlation coefficient. RESULTS: In 2013, 26 patients with cervical cancer were included. A total of 44 gynecological examinations were performed, 44 MRIs and 18 TRUSs. For the comparisons prior to EBRT the correlation coefficient between TRUS vs. MRI was r = 0.79 for AP and r = 0.83 for LL, for GYN vs. MRI was r = 0.6 for AP and r = 0.75 for LL. Prior to BT for GYN vs. MRI, r values were 0.60 and 0.63 for AP and LL, respectively; for GYN vs. TRUS, r values were 0.56 and 0.78 for AP and LL, respectively. CONCLUSIONS: A high correlation between the three examinations was obtained. As such, TRUS can be considered a suitable method in the evaluation of tumor dimensions.
OBJECTIVE: The aim of study was to analyze the accuracy of TRUS (transrectal ultrasound) vs. MRI (magnetic resonance imaging) and clinical gynecological examination estimation in the evaluation of tumor dimensions. METHODS: The patients inclusion criterion included primarily pathologically squamous cell carcinoma, but excluded were patients who had not undergone BT (brachytherapy) and treated with palliative intent. We offer two types of treatment for locally advanced cervical cancer: (a) radiochemotherapy followed by surgery and (b) exclusive radiochemotherapy. Imaging tests follow the presence of tumor and tumor size (width and thickness). Each examination was performed by a different physician who had no knowledge of the others' findings. All patients underwent MRI prior to EBRT (external beam radiation therapy) while 18 of them also at the time of the first brachytherapy application. For the analysis we used the r-Pearson correlation coefficient. RESULTS: In 2013, 26 patients with cervical cancer were included. A total of 44 gynecological examinations were performed, 44 MRIs and 18 TRUSs. For the comparisons prior to EBRT the correlation coefficient between TRUS vs. MRI was r = 0.79 for AP and r = 0.83 for LL, for GYN vs. MRI was r = 0.6 for AP and r = 0.75 for LL. Prior to BT for GYN vs. MRI, r values were 0.60 and 0.63 for AP and LL, respectively; for GYN vs. TRUS, r values were 0.56 and 0.78 for AP and LL, respectively. CONCLUSIONS: A high correlation between the three examinations was obtained. As such, TRUS can be considered a suitable method in the evaluation of tumor dimensions.
Authors: William Small; Jonathan B Strauss; Catherine S Hwang; Leeber Cohen; John Lurain Journal: Int J Gynecol Cancer Date: 2011-07 Impact factor: 3.437
Authors: Johannes C A Dimopoulos; Gerdi Schard; Daniel Berger; Stefan Lang; Gregor Goldner; Thomas Helbich; Richard Pötter Journal: Int J Radiat Oncol Biol Phys Date: 2006-04-01 Impact factor: 7.038
Authors: M P Schmid; R Pötter; P Brader; A Kratochwil; G Goldner; K Kirchheiner; A Sturdza; C Kirisits Journal: Strahlenther Onkol Date: 2012-12-21 Impact factor: 3.621
Authors: Johannes C A Dimopoulos; Gertrude Schirl; Anja Baldinger; Thomas H Helbich; Richard Pötter Journal: Strahlenther Onkol Date: 2009-05-15 Impact factor: 3.621
Authors: Stéphanie Smet; Nicole Nesvacil; Johannes Knoth; Alina Sturdza; Dina Najjari-Jamal; Filip Jelinek; Gernot Kronreif; Richard Pötter; Joachim Widder; Christian Kirisits; Maximilian P Schmid Journal: Strahlenther Onkol Date: 2020-07-03 Impact factor: 3.621